DUNAD THERAPEUTICS LTD.
Research and experimental development on biotechnology
DUNAD THERAPEUTICS LTD.
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Full company profile for DUNAD THERAPEUTICS LTD. (12544797), an active life sciences and medical technology company based in United Kingdom. Incorporated 2 Apr 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2023–2024)
Cash in Bank
£10.18M
Net Assets
£10.09M
Total Liabilities
£2.08M
Turnover
£5.21M
Employees
28
Debt Ratio
17%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (3)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 2 | Mar 2021 | Series A, Seed |
| Investor 1 | Nov 2021 | Series A |
| Investor 3 | Nov 2021 | Series A |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Bonney, Michael Weston | Director | American | United States | 14 Apr 2023 | Active |
| Oakwood Corporate Secretary Limited | Corporate-secretary | United Kingdom | Unknown | 14 Jul 2023 | Active |
See all 13 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Epidarex Capital Iii Uk, Lp
Ceased 14 Aug 2024
Vanessa Lea Mcminn
Ceased 20 Apr 2020
Dziyana Kraskouskaya
Ceased 14 Aug 2024
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 23 Apr 2026 | Confirmation Statement | Confirmation statement made on 1 Apr 2026 with updates | |
| 23 Apr 2026 | Officers | Appointment of Ms Lucy Edwardes Jones as director | |
| 21 Apr 2026 | Officers | Appointment of Mr Michael Bonney as director | |
| 16 Feb 2026 | Capital | Allotment of shares (GBP 10,675.5472) on 3 Feb 2026 | |
| 9 Dec 2025 | Capital | Allotment of shares (GBP 10,675.0402) on 4 Dec 2025 |
Confirmation statement made on 1 Apr 2026 with updates
Appointment of Ms Lucy Edwardes Jones as director
Appointment of Mr Michael Bonney as director
Allotment of shares (GBP 10,675.5472) on 3 Feb 2026
Allotment of shares (GBP 10,675.0402) on 4 Dec 2025
Recent Activity
Latest Activity
Confirmation statement made on 1 Apr 2026 with updates
1 weeks ago on 23 Apr 2026
Appointment of Ms Lucy Edwardes Jones as director
1 weeks ago on 23 Apr 2026
Appointment of Mr Michael Bonney as director
1 weeks ago on 21 Apr 2026
Allotment of shares (GBP 10,675.5472) on 3 Feb 2026
2 months ago on 16 Feb 2026
Allotment of shares (GBP 10,675.0402) on 4 Dec 2025
4 months ago on 9 Dec 2025